Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  
Request a Proposal  

News

Pharm-olam is a global clinical research organization that delivers right-sized trial services to pharmaceutical, biotechnology, government, and public health organizations around the world.

Subscribe

Pharm-Olam Positioning for Growth Trajectory

Pharm-Olam Launches New Protocol Optimization Service

Pharm-Olam recognized by 2020 CRO Leadership Awards second year in a row

Accredited Internationally Qualified Clinical Research Auditor Standard Launches

Pharm-Olam selected to support Revive Therapeutics development of Bucillamine for COVID-19

Pharm-Olam’s Response to COVID-19: Safety, Community, Research

Pharm-Olam names new CEO, Dr. Robert Davie

Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

Pharm-Olam Wins 2019 CRO Leadership Awards

Celebrating 25-Year Anniversary and Enhanced Rare Disease Services

Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study

Orphan Trial leads to First Therapeutic for the Treatment for aTTP

Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos

Pharm-Olam Supports Clinical Trials and Sponsors Compliance with GDPR

Webinar: GDPR Implementation Across Global Clinical Trial Industry

Pharm-Olam LLC Appoints Dr. Kelly McKee as Chief Medical Officer

2017 Winner in CRO Leadership Awards for Second Consecutive Year

Pharm-Olam International Adds John Barry as Chief Operating Officer

Pharm-Olam Webinar: Evolution of Response Evaluation Oncology Trials

Pharm-Olam LLC Announces New Addition to Lead Biostatistics Team

Quad-C Management Announces Investment in Pharm-Olam LLC

Using Medidata Rave improves Data Management & Reporting Capabilities

Pharm-Olam adds New Addition to Quality and Compliance Leadership Team

Webinar: Global Clinical Research Leaders Address Rescue Study Challenges

Pharm-Olam Adds Director of Scientific Development

Pharm-Olam LLC Nominated for 2016 Scrip Awards Best Full-Service CRO

37th Telly Award Winner for Promotion of Allergy Clinical Research

Pharm-Olam Bolsters Client Outreach with Proposals and Contracts hire

Pharm-Olam International Strengthens Country Leadership with Strategic Hire in Mexico

Pharm-Olam International Adds Regional Director, Clinical Operations

Pharm-Olam International Awarded Six CRO Leadership Awards

Pharm-Olam Continues Global Expansion; Adds Full-Service Coverage in Asia-Pacific Region

Pharm-Olam Strengthens Leadership Team with New CFO

Pharm-Olam International Expands to Larger Facility in Poland

Pharm-Olam International Opens a New Office in Paris, France; Continues Global Expansion

Pharm-Olam's Case Study on Automated Sample Retention for BA/BE

Pharm-Olam: Phase III Pulmonary Arterial Hypertension study completed

Pharm-Olam releases a corporate overview video

Webinar: How political events are affecting clinical trials in Ukraine

Pharm-Olam International Celebrates 20-Year Anniversary

Pharm-Olam completes birch and grass pollen allergy studies

Pharm-Olam Expands into Israel

Pharm-Olam expands Clinical Trial Services to Kazakhstan

All posts